Navigation Links
Lucentis in Medical News

Because of Its Ability to Generate Higher Total Sales in the United States and Europe, Lucentis Will Earn Clinical Gold Standard Status by 2011 for the Treatment of Diabetic Retinopathy

A Drug with Superior Efficacy to Avastin at Improving Visual Acuity When Used with Laser Photocoagulation Would Earn a 20 Percent Patient Share, According to a New Report from Decision Resources WALTHAM, Mass., June 26 /PRNewswire/ -- Decision Resources, one of the world's leading ...

Genentech/Roche's Lucentis and Eli Lilly's Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets

Longer Term Growth of Diabetic Neuropathy Market Will Be Driven by Launches of Disease-Modifying Therapies, According to a New Report from Decision Resources WALTHAM, Mass., Sept. 24 /PRNewswire/ -- Decision Resources, one of the world's leading research and advis...

FDA Approval For Lucentis

The first drug proven to significantly improve the vision of elderly patients was approved by the FDA on Friday//. The drug, Lucentis, is to treat age-related macular degeneration in its wet form, where blood vessels behind the retina leak, worsening vision and often leading to blindness. 90 ...

PDL BioPharma Announces Second Quarter 2009 Financial Results

...0 to $325 million excluding MedImmune royalties. Revenue growth expectations are primarily driven by increases in product sales of Avastin, Herceptin, lucentis and Tysabri. PDL expects its general and administrative expenses for 2009 to range from $20 to $22 million, of which approximately 50 percent...

QLT Announces Second Quarter Results for 2009

...tudy is to evaluate whether Visudyne combined with lucentis is not inferior to lucentis monotherapy with respect to the mean change from b...line compared with a 4.4 letter improvement in the lucentis monotherapy group. In the combination therapy grou...

QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy

...tudy is to evaluate whether Visudyne combined with lucentis is not inferior to lucentis monotherapy with respect to the mean change from b...line compared with a 4.4 letter improvement in the lucentis monotherapy group. In the combination therapy grou...

QLT announces positive results from the evaluation of Visudyne(R) combination therapy

...he study is to determine if Visudyne combined with lucentis reduces retreatment rates compared with lucentis monotherapy, while maintaining similar vision outc...entis combination therapies were evaluated against lucentis monotherapy. The overall results showed that fewer...

Burrill & Company Announces Promotions

...Vygantas - Before joining Burrill in 2006, Garrett was with Genentech's Market Planning Group where he focused on the commercialization and launch of lucentis for the treatment of wet age-related macular degeneration. Dr. Vygantas completed his Transitional Residency at the University of Pennsylvania and h...

QLT announces interim results of radical study evaluating Visudyne combination therapy

...ion therapies (with or without dexamethasone) with lucentis monotherapy in 162 subjects with choroidal neovasc...s were lower in the combination groups than in the lucentis monotherapy group; however, it is too early to dra...the mandatory retreatments at month 1 and 2 in the lucentis monotherapy group. The primary endpoint results at...

FDA Grants NeoVista's Request to Utilize Novel Wet AMD Treatment in Compassionate Case

...y and efficacy of NeoVista's epiretinal brachytherapy delivered concomitantly with the FDA-approved anti-VEGF therapy Lucentis(R) (ranibizumab) versus lucentis alone. About NeoVista, Inc. NeoVista, Inc. is a privately held development-stage medical device company based in Fremont , Calif...
Lucentis in Medical Technology

Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

...ported patients who received Xibrom in addition to lucentis (the Combination Group) required 1.6 +/- 0.69 injections of lucentis during the six-month study period, while patients who received lucentis only received 4.5 +/- 0.41 injections (p=0.0002). ...

FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S.

...ngiogenic therapy Lucentis(R) (ranibizumab) versus lucentis alone. For those enrolled in the trial arm utilizing brachytherapy, lucentis is injected once at the time of the surgery and on...y of epiretinal brachytherapy plus Lucentis versus lucentis alone based on the proportion of subjects losing f...

NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society

... of NeoVista's epiretinal beta radiation therapy delivered concomitantly with the FDA-approved antiangiogenic therapy Lucentis(R) (ranibizumab) versus lucentis alone. About NeoVista, Inc. NeoVista, Inc. is a privately held development-stage medical device company based in Fremont, California. NeoVista's e...

ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)

...eceived Xibrom required 1.6 +/- 0.69 injections of lucentis during the six-month study period, while patients who received only lucentis received 4.5 +/- 0.41 injections. Patients with lucentis alone received significantly more (2.83 times) inj...

Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD

...re-FirstCall/ -- Opko Health Inc. (Amex: OPK ) today announced that the first patient has been dosed in the Phase 3 COBALT (Combining Bevasiranib And lucentis Therapy) clinical trial of bevasiranib for the treatment of wet age-related macular degeneration (wet AMD). The multi- national trial will include mor...
Lucentis in Biological Technology

Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe

However, Off-Label Use of Avastin Will Take Market Share Away from Lucentis from 2012 to 2017, According to a New Report from Decision Resources WALTHAM, Mass., March 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcar...

PDL BioPharma Announces First Quarter 2009 Financial Results

... to ongoing legal activities as discussed above. Revenue growth expectations are primarily driven by increases in product sales of Avastin, Herceptin, lucentis and Tysabri. PDL continues to expect its general and administrative expenses for 2009 to range from $12 million to $15 million, of which approxi...

EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention

...earn videos about eye anatomy, AMD symptoms, dry and wet macular degeneration, diagnostic tests, photodynamic therapy (PDT), intravitreal injection of lucentis and Avastin, vitamin therapy, amsler grid testing, lasers and more. Users also have the ability to browse an FAQ section, which contains expert ...
Other Tags
(Date:7/9/2014)... types of cancer sends the protein factories in our ... uncontrolled growth, new research suggests. , Scientists at The ... responsible for ratcheting up activity of the endoplasmic reticulum ... blocks cancer cells need to keep growing. , A ... the flow of messages to the endoplasmic reticulum telling ...
(Date:7/9/2014)... that fecal transplantation is effective and safe for treating ... the result of a study led by Colleen Kelly, ... Medicine at The Women,s Medicine Collaborative. The study and ... print in the American Journal of Gastroenterology . ... , has increased to epidemic proportions over the past ...
(Date:7/9/2014)... There has been a sharp increase in the ... using MyChart, the online, interactive service that allows patients ... healthcare providers, schedule appointments, and renew prescriptions. , Over ... MyChart each year increased five-fold, while the ... 10-fold, according to a study by Dr. David ...
(Date:7/9/2014)... Allergy and Infectious Diseases (NIAID), part of the ... clinical trial of CRS3123, an investigational oral antibiotic ... C. difficile ) infection. CRS3123 (previously known as ... difficile growth while sparing normal intestinal bacteria. , ... 30 healthy men and women ages 18 to ...
(Date:7/9/2014)... , , , , , ... , , , , , ... binaural recording using KEMAR, the weapon was an SA80 assault rifle and the microphone is 50m downrange from the firer and approximately 30cm from the bullet... ... , , , , ... , , , , , ...
Breaking Medicine News(10 mins):Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7
(Date:7/9/2014)... of increasing concern about the prevalence of antibiotic-resistant ... promising new pathway to disabling disease: blocking bacteria,s ... scientists showed how bacterial siderophore, a small molecule, ... fan bacterial growth as well as how ... infection process. Their findings appear in a recent ...
(Date:7/9/2014)... season upon us, many backyard cooks are turning to ... dogs. But low fat can sometimes mean low satisfaction. ... texture problem in low-fat wieners that are made with ... published in ACS, Journal of Agricultural and Food ... that hot-dog consumers have come to expect just the ...
(Date:7/9/2014)... re-examination of a sparrow-sized fossil from China challenges the ... dinosaurs that gained the ability to fly. The birdlike ... but much rather the remains of a tiny tree-climbing ... of the Dinosaur Museum in Blanding, Utah, and Alan ... appears in Springer,s Journal of Ornithology . , ...
Breaking Biology News(10 mins):Bacteria hijack plentiful iron supply source to flourish 2Researchers declassify dinosaurs as being the great-great-grandparents of birds 2
Other Contents